FocusPoint Bolsters North American Fundraising Team with Addition of Two Senior Marketers
FocusPoint Private Capital Group (“FocusPoint”), an independent capital raising and advisory firm, announced the addition of Erica Johnson and Franklyn Chang to the FocusPoint team. “With a growing pipeline and increased market demand, we are pleased announce the additions of Erica Johnson and Franklyn Chang to our fundraising platform” said David Conrod, Chief Executive of FocusPoint.
Erica Johnson joins as Managing Director and will primarily be responsible for distribution and origination initiatives. Previously, Ms. Johnson was Founder and CEO of ERJ Group, an independent capital raising business Ms. Johnson formed after a successful career with Guggenheim Partners.
“Erica was always one of our top producers at Guggenheim Partners during that time. We identified, sourced, seeded and launched several private funds. Erica has a deep understanding of the entire sales process which will be extremely valuable to our General Partner clients working closely with our team of marketers,” Conrod stated.
Erica commented “I am very excited to be working again with several former Guggenheim colleagues as FocusPoint continues to provide high quality fund offerings to the institutional marketplace.”
Frank Chang joins as Managing Director and will also be responsible for distribution and origination initiatives. Areas of focus for Frank will be the upper Midwest, Northeast, Texas and EMEA. Previously, Mr. Chang had a successful career in-house including nine years at Eaton Partners, where he was head of its London office at one point. Frank’s insight will be valuable as FocusPoint thinks through next steps with respect to increased coverage in Europe and the Gulf.
“Frank has always been a top performer and extremely knowledgeable on the private capital markets and we’re excited to have someone with Frank’s many accomplishments in all aspects of institutional capital raising.”
Frank commented “I am very excited to join the FocusPoint team which has an established platform and experienced team also offering creative solutions and partnering oriented service that differentiates the firm amongst its peers.”
# # #
About FocusPoint Private Capital Group
FocusPoint Private Capital Group is an independent capital raising firm specializing in private capital markets and a wholly-owned affiliated LANDC Investment LLC. The firm focuses on raising capital for private equity, credit, real estate, real assets and direct transactions in both developed and emerging markets. FocusPoint advises on all aspects of the fundraising process, including competitive positioning and market assessment, marketing materials and related documentation, partnership terms and conditions as well as investor relations. The firm utilizes a rigorous manager selection and due diligence process. FocusPoint’s global distribution capability extends to endowments, foundations, corporate and public pension funds, ultra-high net worth families, sovereign wealth funds and other limited partners throughout the U.S., Europe, Middle East and Asia. Over the past decade, the senior team of professionals has been dedicated to developing and fostering these relationships. FocusPoint operates as a FINRA regulated broker-dealer in the U.S. and is a member of SIPC.
About LANDC Investment LLC
LANDC Investment LLC is a financial services firm with two complementary platforms. FocusPoint Private Capital Group, an independent capital raising and advisory firm specializing in providing fundraising services to high quality General Partners, was acquired when LANDC was formed in 2014. In 2017 LANDC launched an asset management platform with the launch of Rise Line Business Credit, a specialty finance asset-based lending firm. Along with equity ownership in Rise Line, LANDC has secured equity and carried interest stakes in select funds and direct transactions for providing advisory and capital raising services. LANDC is led by principals with decades of experience in capital placement and investment management.